133 related articles for article (PubMed ID: 17684930)
1. [Cellular tumor markers in thyroid cancer].
Kopczyńska E; Kwapisz J; Junik R; Tyrakowski T
Pol Merkur Lekarski; 2007 Apr; 22(130):295-9. PubMed ID: 17684930
[TBL] [Abstract][Full Text] [Related]
2. The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer.
Weber KB; Shroyer KR; Heinz DE; Nawaz S; Said MS; Haugen BR
Am J Clin Pathol; 2004 Oct; 122(4):524-31. PubMed ID: 15487449
[TBL] [Abstract][Full Text] [Related]
3. [Biological investigation of thyroid cancer].
Douik H; Ghanem A; Jmal A; Harzallah L; Gara S; Abdennebi M; Boussen H; Guemira F
Tunis Med; 2006 Mar; 84(3):135-41. PubMed ID: 16755952
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in the clinical application of thyroid cancer biomarkers.
Shibru D; Chung KW; Kebebew E
Curr Opin Oncol; 2008 Jan; 20(1):13-8. PubMed ID: 18043251
[TBL] [Abstract][Full Text] [Related]
5. Molecular markers in thyroid cancer diagnostics.
Kato MA; Fahey TJ
Surg Clin North Am; 2009 Oct; 89(5):1139-55. PubMed ID: 19836489
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers for the diagnosis of thyroid cancer.
Sethi K; Sarkar S; Das S; Mohanty B; Mandal M
J Exp Ther Oncol; 2010; 8(4):341-52. PubMed ID: 21222366
[TBL] [Abstract][Full Text] [Related]
7. Circulating thyroid cancer markers.
Gupta M; Chia SY
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers.
Griffith OL; Melck A; Jones SJ; Wiseman SM
J Clin Oncol; 2006 Nov; 24(31):5043-51. PubMed ID: 17075124
[TBL] [Abstract][Full Text] [Related]
9. Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.
Wiseman SM; Melck A; Masoudi H; Ghaidi F; Goldstein L; Gown A; Jones SJ; Griffith OL
Ann Surg Oncol; 2008 Oct; 15(10):2811-26. PubMed ID: 18612701
[TBL] [Abstract][Full Text] [Related]
10. Peripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillance.
Barbosa GF; Milas M
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1415-24. PubMed ID: 18759693
[TBL] [Abstract][Full Text] [Related]
11. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnostic methods in the diagnosis and follow-up of well-differentiated thyroid carcinoma.
Rodrigo JP; Rinaldo A; Devaney KO; Shaha AR; Ferlito A
Head Neck; 2006 Nov; 28(11):1032-9. PubMed ID: 16732600
[TBL] [Abstract][Full Text] [Related]
13. Thyroid tumors.
Seesko HG; Wells SA
Immunol Ser; 1990; 53():431-52. PubMed ID: 2100571
[No Abstract] [Full Text] [Related]
14. Thyroid tumorigenesis and molecular markers in thyroid cancer.
Kouniavsky G; Zeiger MA
Curr Opin Oncol; 2010 Jan; 22(1):23-9. PubMed ID: 19907326
[TBL] [Abstract][Full Text] [Related]
15. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
16. Biomarker panel diagnosis of thyroid cancer: a critical review.
Griffith OL; Chiu CG; Gown AM; Jones SJ; Wiseman SM
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1399-413. PubMed ID: 18759692
[TBL] [Abstract][Full Text] [Related]
17. Tumor marker determinations.
Lukinac L; Kusić Z; Franceschi M; Pokrajac B; Bolanca A; Nöthig-Hus D
Acta Med Iugosl; 1991; 45(3):245-50. PubMed ID: 1950643
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
[TBL] [Abstract][Full Text] [Related]
19. Atypical thyroid nodules express both HBME-1 and Galectin-3, two phenotypic markers of papillary thyroid carcinoma.
Coli A; Bigotti G; Parente P; Federico F; Castri F; Massi G
J Exp Clin Cancer Res; 2007 Jun; 26(2):221-7. PubMed ID: 17725102
[TBL] [Abstract][Full Text] [Related]
20. Laboratory services for thyroglobulin and implications for monitoring of differentiated thyroid cancer.
Clark PM
J Clin Pathol; 2009 May; 62(5):402-6. PubMed ID: 19398593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]